Suven Life Sciences Fair Value
Suven Life Sciences (SUVEN) average fair value is ₹277.33 across 3 valuation models — P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, vs a current market price of ₹267.15 (+3.81%), fair value range ₹1.19–₹603.5. See SUVEN price book multiple to compare market price against book value per share.
Fair Value Analysis Export
SUVEN Fair Value vs Current Price — Valuation Summary
SUVEN average fair value, fair value range, price gap and valuation status across 3 models: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation. Examine SUVEN earnings report for recent quarterly revenue, profit and EPS trends.
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
SUVEN Fair Value Analysis — Data Sources & Coverage
Suven Life Sciences financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. For live price and a broader fundamental view, visit Suven Life Sciences share price today.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
SUVEN vs Healthcare Sector Peers — P/E, P/B & Market Cap
Suven Life Sciences P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Accretion Pharmaceuticals | ACCPL | 13.72 | 2.43 | ₹131 |
| Par Drugs & Chemical | PAR | 8.67 | 1.01 | ₹111 |
| Jeena Sikho Lifecare | JSLL | 40.02 | 22.33 | ₹7,891 |
| Auro Laboratories | AUROLAB | 91.49 | 3.91 | ₹165 |
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.